{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:06:26Z","timestamp":1789632386922,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"None"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05158-5","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T19:12:35Z","timestamp":1776885155000},"page":"4049-4055","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical significance of the combined systematic 12-core with concomitant MRI image-guided targeted prostate biopsy: can the MRI targeted biopsy stand on its own?"],"prefix":"10.1007","volume":"58","author":[{"suffix":"Jr.","given":"Charles A.","family":"Seabury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousif M.","family":"Shakroo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharam M.","family":"Ramnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7967-238X","authenticated-orcid":false,"given":"Junqi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Seabury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"5158_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P (2019) Epidemiology of prostate cancer. World J Oncol 10:63\u201389","journal-title":"World J Oncol"},{"key":"5158_CR2","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.15585\/mmwr.mm6941a1","volume":"69","author":"DA Siegel","year":"2020","unstructured":"Siegel DA, O\u2019Neil ME, Richards TB et al (2020) Prostate cancer incidence and survival, by stage and race\/ethnicity\u2014United States, 2001\u20132017. MMWR Morb Mortal Wkly Rep 69:1473\u20131480","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"5158_CR3","first-page":"209","volume":"71","author":"HF Sung","year":"2020","unstructured":"Sung HF (2020) Global cancer statistics: GLOBOCAN esimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"5158_CR4","first-page":"1","volume":"22","author":"SK Pandian","year":"2018","unstructured":"Pandian SK, Hammadeh M, Challacombe B, Popert R, Madaan S (2018) History of prostate biopsy\u2014part 1. Urol Times 22:1\u20133","journal-title":"Urol Times"},{"key":"5158_CR5","first-page":"1","volume":"2019","author":"F Drost","year":"2019","unstructured":"Drost F, Osses D, Nieboer D, Steyerberg E et al (2019) Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. Cochrane Database Syst Rev 2019:1\u2013218","journal-title":"Cochrane Database Syst Rev"},{"key":"5158_CR6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","volume":"76","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz A, Haider M et al (2019) Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol 76:340\u2013351","journal-title":"Eur Urol"},{"key":"5158_CR7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.eururo.2014.11.037","volume":"68","author":"I Schoots","year":"2015","unstructured":"Schoots I, Roobol M, Nieboer D et al (2015) Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. Eur Urol 68:438\u2013450","journal-title":"Eur Urol"},{"key":"5158_CR8","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.urolonc.2013.08.006","volume":"32","author":"G Sonn","year":"2014","unstructured":"Sonn G, Margolis D, Marks L (2014) Target detection: magnetic resonance imaging-ultrasound fusion-guided prostate biopsy. Urol Oncol 32:903\u2013911","journal-title":"Urol Oncol"},{"key":"5158_CR9","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.juro.2017.04.101","volume":"198","author":"P Fulgham","year":"2017","unstructured":"Fulgham P, Rukstalis D, Turkbey B et al (2017) AUA policy statement on the use of multiparametric magnetic resonance imaging in the diagnosis, staging and management of prostate cancer. J Urol 198:832\u2013838","journal-title":"J Urol"},{"key":"5158_CR10","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1056\/NEJMoa2209454","volume":"387","author":"J Hugosson","year":"2022","unstructured":"Hugosson J, M\u00e5nsson M, Wallstr\u00f6m J et al (2022) Prostate cancer screening with PSA and MRI followed by targeted biopsy only. N Engl J Med 387:2126\u20132137","journal-title":"N Engl J Med"},{"key":"5158_CR11","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.21037\/tau.2019.09.37","volume":"9","author":"A Moe","year":"2020","unstructured":"Moe A, Hayne D (2020) Transrectal ultrasound biopsy of the prostate: does it still have a role in prostate cancer diagnosis? Trans Androl Urol 9:3018\u20133024","journal-title":"Trans Androl Urol"},{"key":"5158_CR12","doi-asserted-by":"publisher","first-page":"E293","DOI":"10.5489\/cuaj.1248","volume":"7","author":"EC Serefoglu","year":"2013","unstructured":"Serefoglu EC, Altinova S, Ugras NS et al (2013) How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer? Can Urol Assoc J 7:E293\u2013E298","journal-title":"Can Urol Assoc J"},{"key":"5158_CR13","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1056\/NEJMoa1910038","volume":"382","author":"M Ahdoot","year":"2020","unstructured":"Ahdoot M, Wilbur A, Reese S et al (2020) MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis. N Engl J Med 382:917\u2013928","journal-title":"N Engl J Med"},{"key":"5158_CR14","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3390\/diagnostics11081335","volume":"11","author":"E Gomez-Gomez","year":"2021","unstructured":"Gomez-Gomez E, Moreno Sorribas S, Valero-Rosa J et al (2021) Does adding standard systematic biopsy to targeted prostate biopsy in PI-RADS 3 to 5 lesions enhance the detection of clinically significant prostate cancer? Should all patients with PI-RADS 3 undergo targeted biopsy? Diagnostics 11:1335","journal-title":"Diagnostics"},{"key":"5158_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.899567","volume":"12","author":"M Parsons","year":"2022","unstructured":"Parsons M, Sandhu Z, Foy B et al (2022) Concordance of MRI-guided fusion and systematic 12-core prostate biopsy for the detection of prostate cancer. Front Oncol 12:899567","journal-title":"Front Oncol"},{"issue":"2","key":"5158_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.euo.2020.02.005","volume":"3","author":"A Stabile","year":"2020","unstructured":"Stabile A, Giganti F, Kasivisvanathan V (2020) Factors influencing variability in the performance of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer: a systematic literature review. Eur Urol Oncol 3(2):145\u2013167","journal-title":"Eur Urol Oncol"},{"issue":"6","key":"5158_CR17","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1097\/JU.0000000000001302","volume":"204","author":"G Song","year":"2020","unstructured":"Song G, Ruan M, Wang H (2020) How many targeted biopsy cores are needed for clinically significant prostate cancer detection during transperineal magnetic resonance imaging\u2013ultrasound fusion biopsy? J Urol 204(6):1202\u20131208","journal-title":"J Urol"},{"key":"5158_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.urology.2024.12.033","volume":"197","author":"CN Brodsky","year":"2025","unstructured":"Brodsky CN, Daignault-Newton S, Davenport MS (2025) How many cores should be collected per region of interest in fusion targeted prostate biopsy? A retrospective single-institution statistical simulation. Urology 197:133\u2013140","journal-title":"Urology"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05158-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05158-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05158-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:52:42Z","timestamp":1789631562000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05158-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":18,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["5158"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05158-5","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}